Overview
Xiaojian Han practices practicing medicine in Chongqing, China.
Their clinical expertise encompasses PEPCK 1 Deficiency, PIK3CA-Related Overgrowth Spectrum, Severe Acute Respiratory Syndrome (SARS), and Inflammatory Breast Cancer.
They are actively involved in clinical research, co-authoring 20 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xiaojian Han
Is Xiaojian Han a top-rated expert for PEPCK 1 Deficiency?
MediFind is an objective health platform that identifies experts based on real-world data. Xiaojian Han is classified as an Experienced expert for PEPCK 1 Deficiency, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xiaojian Han participate in research or clinical trials?
Yes. Xiaojian Han has published 20 articles and abstracts on conditions like PEPCK 1 Deficiency. You can view a list of Xiaojian Han's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Inflammatory Breast Cancer
- PEPCK 1 DeficiencyHan isExperienced. Learn about PEPCK 1 Deficiency.
- PIK3CA-Related Overgrowth Spectrum
- Severe Acute Respiratory Syndrome (SARS)